| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 04/28/2005 | US20050090688 Metallized mesoporous silicate and method of oxidation with the same |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090484 Purification of natural, synthetic or semi-synthetic crude harringtonines by reverse phase chromatography and crystallization; solvent is water or lower alkanol, or an aqueous mixture of organic solvents; enantiomerically pure; industrial scale; leukemia chemotherapy |
| 04/28/2005 | US20050090452 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae |
| 04/28/2005 | US20050090381 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 04/28/2005 | US20050089584 Nut extract having different alkaloid profile; reduced level of carcinogens; supercritical CO2 extraction; maintaining nutraceutical effects; rapidly dissolving tablets |
| 04/28/2005 | CA2549733A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | CA2540207A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | CA2540191A1 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 04/27/2005 | EP1463723A4 Process for the preparation of simvastatin |
| 04/27/2005 | EP1144360B1 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 04/27/2005 | CN1198823C Phenyl substituted 4-hydroxy tetrahydropyridone |
| 04/27/2005 | CN1198508C Cyclohexenone oxime ether/(glyphosates/gluphosinates) suspension concentrates |
| 04/26/2005 | US6884897 Preparation of 3,6-dihydro-2H-pyran-2-carboxylic esters |
| 04/21/2005 | WO2005035529A1 Substituted phenanthropyrans |
| 04/21/2005 | WO2005035515A1 A method for the manufacture of lovastatin |
| 04/21/2005 | WO2005035489A2 Improved synthesis of discodermolide and variants thereof |
| 04/21/2005 | WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | WO2005034856A2 Targeted drug-formaldehyde conjugates and methods of making and using the same |
| 04/21/2005 | WO2004098582A3 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085413 Dimeric pharmaceutical compounds and their use |
| 04/21/2005 | CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/20/2005 | EP1524267A1 Substituted benzylaminoalkylene heterocycles |
| 04/20/2005 | EP1523542A1 Fragrance composition |
| 04/20/2005 | EP1470118B1 Alpha-methylenelactone synthesis in supercritical fluids |
| 04/20/2005 | EP1204637B1 Process for the preparation of isotretinoin |
| 04/20/2005 | CN1197856C Red fluorescence dyestuff and its synthesizing method and usage |
| 04/20/2005 | CN1197855C Organic compound with bi-4-dicyan methylene pyranoid ring and its synthetic method and use |
| 04/20/2005 | CN1197854C Lactonization processing method in preparing Tating compounds |
| 04/14/2005 | US20050080276 Process for producing lactone |
| 04/14/2005 | US20050080275 Process for the preparation of simvastatin |
| 04/14/2005 | US20050080080 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 04/14/2005 | US20050079587 Beginning with diastereo-and enantioselective reduction of a keto ester to obtain the hydroxy ester; use in drug preparation |
| 04/13/2005 | EP1458702B1 Luminacin analogs and uses thereof |
| 04/13/2005 | CN1606543A Alpha-cyanoacrylates |
| 04/12/2005 | US6878736 Histamine H3 receptor ligands |
| 04/12/2005 | US6878727 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 04/12/2005 | US6878704 Heterocyclic mutilin esters and their use as antibacterials |
| 04/07/2005 | WO2005030188A2 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 04/07/2005 | US20050075514 Process for the oxidation of organic substrates and a catalyst composition for carrying out the process |
| 04/07/2005 | US20050075390 HIV protease inhibitors |
| 04/07/2005 | US20050075389 Pharmacologically active novel dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same |
| 04/07/2005 | US20050075374 Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
| 04/07/2005 | US20050075344 Melanocortin receptor agonists |
| 04/07/2005 | CA2540186A1 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 04/06/2005 | EP1520472A2 Herbicidal compositions comprising pyridoyl-1,3-cyclodiones |
| 04/06/2005 | EP1519931A2 Chiral 3,4-dihydro-2h-pyran compounds |
| 04/06/2005 | EP1392656A4 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 04/06/2005 | CN1604780A Use of rosuvastatin in pre demented states |
| 04/05/2005 | US6875867 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 04/05/2005 | US6875791 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| 03/31/2005 | WO2005028463A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | WO2005028457A1 Preparation of quetiapine |
| 03/31/2005 | WO2005028429A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 03/31/2005 | WO2005028409A1 Alpha-hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds |
| 03/31/2005 | US20050070599 Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide |
| 03/31/2005 | US20050070598 Using 4-oxot perhydro( furan or pyran)-3-yl carbamoyl derivative; bone disorders; oral disease; antiarthritic agents |
| 03/31/2005 | US20050070539 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 03/31/2005 | US20050069596 Compositions and methods comprising kava and anti-anxiety compounds |
| 03/31/2005 | CA2539165A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | CA2539162A1 Cinnamoyl derivatives and use thereof |
| 03/31/2005 | CA2521811A1 Haloalkyl containing compounds as cysteine protease inhibitors |
| 03/30/2005 | EP1517879A1 Aminoalkylphenols, methods of using and making the same |
| 03/30/2005 | EP1302469B1 Process for producing hydroxylactone |
| 03/30/2005 | CN1600772A Aryl phenyl substituted cyclic ketoenols |
| 03/30/2005 | CN1600117A Stabilizer FLIOO for milk beverage in ultra low viscosity |
| 03/24/2005 | WO2005026171A1 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d¸6,5-d']dipyrimidyne and 10-aza-analogue thereof |
| 03/24/2005 | WO2005025557A1 An agent for plasminogen-activation and matrix metalloproteinase associated conditions and methods of use |
| 03/24/2005 | WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor |
| 03/24/2005 | WO2004099132A3 Process for the preparation of trans-isomers of diphenylazetidinone derivatives |
| 03/24/2005 | WO2004074249A3 Synthesis of peloruside a and analogs thereof for use as antitumor agents |
| 03/24/2005 | WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 03/24/2005 | US20050065353 Mitosis agents; antitumor agents; anticancer agents |
| 03/23/2005 | EP1516879A1 Process for producing pyran |
| 03/23/2005 | EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 03/23/2005 | EP1515940A2 Aminoalkoxy-functional chalcones |
| 03/23/2005 | EP1515931A1 3,3,4,4-tetrafluorocyclopentane compounds, used as components of liquid crystal media |
| 03/23/2005 | CN1193992C Synthesis of 3.6-dialkyl 5.6-dihydro-4-hydroxide-2H-pyran-2-ketone |
| 03/22/2005 | US6870059 Acetalization of heterocyclic esters in the presence of acid catalyst, to form compounds such as 2-(6-hydroxymethyl-1,3-dioxane-4-yl)acetic acid, t-butyl ester, used as chemical intermediates for statins |
| 03/22/2005 | US6870058 Polyhydroxy, dienyl lactones and intermediates |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/17/2005 | WO2005023261A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | WO2005023260A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 03/17/2005 | US20050059833 Process for producing pyran |
| 03/17/2005 | US20050059668 Substituted acylpiperazine derivatives |
| 03/17/2005 | CA2538135A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | CA2537292A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/16/2005 | EP1514873A1 Process for oxidation of organic substrates and catalyst compositions for performing the same |
| 03/16/2005 | EP1250047B1 Herbicidal composition |
| 03/16/2005 | CN1193022C Lactonization method in course of preparing lovastatin or similarities |
| 03/16/2005 | CN1193021C Processes for producing tetrahydropyranyl-4 sulfonate and 4-amino tetrapyran compound |
| 03/15/2005 | US6867333 Epothilone synthesis building blocks iii and iv: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones b, d and epothilone derivatives |
| 03/15/2005 | US6867161 Titanium catalyst and organotitanium reacting reagent, production thereof, and reaction thereby |
| 03/10/2005 | US20050054719 Dimeric compounds and their use as anti-viral agents |
| 03/10/2005 | US20050054718 4S, 5R, 6R)-5-Acetylamino-4-azido-6-[(S)-4-nitrophenoxycarbonyloxy)-(2-oxo-[1,3]dioxolan-4R-yl)methyl]- 5,6-dihydro-4H-pyran2-carboxylic acid methylester; modified at the carboxyl or hydroxyl or amino functions; orthomyxovirus and paramyxovirus infections; a long lung residency time and high potency |
| 03/10/2005 | US20050054629 Antiproliferative agents; anticancer agents; restenosis |